Related Experiment Video
Updated: Jul 13, 2026

Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
Application of PCR technology in vaccine product development
Jayanthi J Wolf1, Liman Wang, Fubao Wang
1Merck Research Laboratories, Biologics Safety Assessment, Merck & Co., Inc., PO Box 4, WP45-338, West Point, PA 19486, USA. jayanthi_wolf@merck.com
Abstract:
The complex process of vaccine product development needs to be tightly controlled and closely monitored to ensure vaccine quality and consistency. Since its inception, PCR has been widely used in all stages of vaccine product development as a tool to assist in the evaluation of vaccine quality, safety and efficacy. In this review, the general principles of conventional and real-time quantitative PCR (Q-PCR) technology and its application in vaccine product development for quantitation of vaccine dose (genome quantitation assay), infectivity (Q-PCR-based potency assay), process residuals, stability, adventitious agents, safety assessment and clinical studies are described. The future outlook and the advantages and disadvantages of this technology are also discussed.
More Related Videos
04:43Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction
Published on: October 11, 2024
09:57Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids
Published on: March 17, 2016
Related Concept Videos
Real Time RT-PCR
The real-time quantification of the number of amplified products is...
Vaccine Production
PCR
PCR - Polymerase Chain Reaction